Detalles de la búsqueda
1.
Patterns of publicly funded naltrexone use among patients diagnosed with alcohol use disorder in Ontario.
Alcohol Alcohol
; 59(2)2024 Jan 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38300604
2.
Initiation of opioid agonist therapy after hospital visits for opioid poisonings in Ontario.
CMAJ
; 195(49): E1709-E1717, 2023 Dec 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38110219
3.
Guidance on take-home naloxone distribution and use by community overdose responders in Canada.
CMAJ
; 195(33): E1112-E1123, 2023 08 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37640401
4.
From design to action: participatory approach to capacity building needs for local overdose response plans.
BMC Public Health
; 23(1): 774, 2023 04 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37101181
5.
Considerations for the design of overdose education and naloxone distribution interventions: results of a multi-stakeholder workshop.
BMC Public Health
; 23(1): 888, 2023 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37189052
6.
A rapid review of current engagement strategies with people who use drugs in monitoring and reporting on substance use-related harms.
Harm Reduct J
; 20(1): 169, 2023 11 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37964286
7.
Design details for overdose education and take-home naloxone kits: Codesign with family medicine, emergency department, addictions medicine and community.
Health Expect
; 25(5): 2440-2452, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35909312
8.
Supporting community overdose response planning in Ontario, Canada: Findings from a situational assessment.
BMC Public Health
; 22(1): 1390, 2022 07 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35854231
9.
Priority setting for Canadian Take-Home Naloxone best practice guideline development: an adapted online Delphi method.
Harm Reduct J
; 19(1): 71, 2022 07 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35780136
10.
Responding to Ontario's Overdose Crisis in the Context of the COVID-19 Pandemic.
Healthc Q
; 25(2): 7-12, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36153678
11.
Take-home naloxone programs for suspected opioid overdose in community settings: a scoping umbrella review.
BMC Public Health
; 21(1): 597, 2021 03 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33771150
12.
One-Year Mortality After Emergency Department Visit for Nonfatal Opioid Poisoning: A Population-Based Analysis.
Ann Emerg Med
; 75(1): 20-28, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31561997
13.
Assessing the public health impact of cannabis legalization in Canada: core outcome indicators towards an 'index' for monitoring and evaluation.
J Public Health (Oxf)
; 41(2): 412-421, 2019 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29860521
14.
Quality of primary care among individuals receiving treatment for opioid use disorder.
Can Fam Physician
; 65(5): 343-351, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31088874
15.
Opioid agonist therapy during residential treatment of opioid use disorder: Cohort study on access and outcomes.
Can Fam Physician
; 65(10): e443-e452, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31604755
16.
Document d'orientation sur la distribution et l'utilisation de trousses de naloxone à emporter par les intervenants et intervenantes communautaires en cas de surdose au Canada.
CMAJ
; 195(38): E1312-E1325, 2023 10 03.
Artículo
en Francés
| MEDLINE | ID: mdl-37788838
17.
Can naloxone prescription and overdose training for opioid users work in family practice? Perspectives of family physicians.
Can Fam Physician
; 61(6): 538-543, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30207979
18.
Characteristics, treatment patterns and retention with extended-release subcutaneous buprenorphine for opioid use disorder: A population-based cohort study in Ontario, Canada.
Drug Alcohol Depend
; 254: 111032, 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38043224
19.
Defining a public health approach to substance use: Perspectives from professionals and practitioners across Canada.
Int J Drug Policy
; 128: 104427, 2024 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38663158
20.
Characteristics of Opioid Toxicity Deaths Among Adolescents and Young Adults in Ontario Prior To and During the COVID-19 Pandemic.
J Adolesc Health
; 75(1): 35-42, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38597841